Bio-Rad Laboratories, Inc.
(NYSE : BIO)

( )
BIO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 2.21%416.231.0%$504.54m
DHRDanaher Corp. 3.00%206.000.7%$482.10m
ISRGIntuitive Surgical, Inc. 1.20%683.092.4%$454.50m
ABTAbbott Laboratories 1.62%100.660.8%$454.05m
MDTMedtronic Plc 1.35%102.080.6%$450.16m
DXCMDexCom, Inc. 4.07%427.898.3%$366.42m
BDXBecton, Dickinson & Co. 0.82%257.101.0%$330.21m
BSXBoston Scientific Corp. 1.68%39.971.0%$313.26m
INOInovio Pharmaceuticals, Inc. -5.95%13.755.9%$304.55m
VARVarian Medical Systems, Inc. 0.11%173.489.1%$298.85m
BAXBaxter International, Inc. 0.66%83.491.8%$272.99m
ALGNAlign Technology, Inc. 1.27%307.986.4%$268.02m
SYKStryker Corp. 0.62%190.091.3%$252.42m
EWEdwards Lifesciences Corp. 2.53%78.600.4%$206.68m
QDELQuidel Corp. 4.36%239.597.7%$194.89m

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.